Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-04 4:51 pm Purchase | 2025-05-28 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Frazier Life Sciences Public Fund, L.P. | 5,500,812 9.900% | 5,500,812 (New Position) | Filing History |
| 2025-06-04 4:04 pm Purchase | 2025-05-28 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Affinity Healthcare Fund, LP | 4,252,005 7.750% | 4,252,005 (New Position) | Filing History |
| 2025-05-15 09:58 am Sale | 2025-03-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | D1 Capital Partners L.P. | 978,652 2.900% | -1,527,955 (-60.96%) | Filing History |
| 2025-05-14 12:00 pm Purchase | 2025-03-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 4,557,920 13.700% | 218,666 (+5.04%) | Filing History |
| 2025-05-13 06:55 am Purchase | 2025-03-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | MIZUHO FINANCIAL GROUP INC | 2,203,631 6.600% | 276,700 (+14.36%) | Filing History |
| 2025-05-12 09:00 am Sale | 2025-03-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Adage Capital Management, L.P. | 237,953 0.700% | -1,971,662 (-89.23%) | Filing History |
| 2025-04-28 4:03 pm Purchase | 2025-04-22 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Integrated Core Strategies (US) LLC | 1,933,379 5.800% | 1,933,379 (New Position) | Filing History |
| 2025-02-14 12:03 pm Sale | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Eventide Asset Management, LLC | 1,234,834 3.730% | -621,152 (-33.47%) | Filing History |
| 2025-02-14 11:55 am Purchase | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 4,339,254 13.100% | 576,059 (+15.31%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Omega Fund VI, L.P. | 1,184,636 3.600% | -972,987 (-45.10%) | Filing History |
| 2025-02-13 10:24 am Purchase | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | MIZUHO FINANCIAL GROUP INC | 1,926,931 5.800% | 1,926,931 (New Position) | Filing History |
| 2025-02-12 09:35 am Sale | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Adage Capital Management, L.P. | 2,209,615 6.680% | -388,121 (-14.94%) | Filing History |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | BlackRock Inc. BLK | 1,821,966 5.500% | 1,821,966 (New Position) | Filing History |
| 2024-11-14 5:49 pm Sale | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Lundbeckfond Invest A/S | 942,671 2.900% | -893,288 (-48.66%) | Filing History |
| 2024-11-14 4:45 pm Purchase | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Longitude Capital Partners IV LLC | 2,765,381 8.400% | 198,281 (+7.72%) | Filing History |
| 2024-11-14 12:32 pm Purchase | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 3,763,195 11.400% | 369,908 (+10.90%) | Filing History |
| 2024-11-14 12:23 pm Sale | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Eventide Asset Management, LLC | 1,855,986 5.610% | -336,225 (-15.34%) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Adage Capital Management, L.P. | 2,597,736 7.860% | 2,597,736 (New Position) | Filing History |
| 2024-08-09 09:43 am Sale | 2024-07-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Eventide Asset Management, LLC | 2,192,211 6.650% | -810,620 (-27.00%) | Filing History |
| 2024-08-05 12:54 pm Purchase | 2024-07-25 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 3,393,287 10.300% | 1,062,549 (+45.59%) | Filing History |